FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy
Clinical trial NCT00125723 · COMPLETED
Trial details
- NCT number
- NCT00125723
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2005-12-01
- Enrollment
- 2252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.